Skinvisible, Inc. SKVI Archives

ThursdayFeb 22, 2018 4:15 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Preparing to Enter the Post-Surgical Pain Management Market through Proposed Merger

Research and development company Skinvisible (OTCQB: SKVI) previously announced the signing of a Letter of Intent for a proposed merger with Quoin Pharmaceuticals Limited, which would successfully mark the company’s entrance into the post-surgical pain management market. The partnership has the potential to address significant unmet medical needs on the pain management market. An article discussing the company’s endeavor reads: “Currently, the pain management market in the U.S. is fueled by a number of sectors. The most prominent ones include post-operative pain relief, arthritis pain, cancer pain, migraine and neuropathic pain. As larger Western populations age and become susceptible to…

WednesdayFeb 21, 2018 3:41 pm

Skinvisible, Inc. (SKVI) Aims to Increase Shareholder Value through Proposed Deal with Quoin

Drug delivery platform ideal for M&A-driven growth $80 billion global dermatology market $30 billion global over-the-counter skincare market Half of the 100 million surgeries performed in the U.S. require post-surgical pain medication, according to Transparency Market Research report If history repeats itself, as we are often told, then Skinvisible, Inc.’s (OTCQB: SKVI) proposed deal with Quoin Pharmaceuticals Limited ("Quoin") could increase shareholder value after execution. In late 2017, the company announced its plan to merge with Quoin, a marriage made in heaven that combines Skinvisible’s virtues as a drug delivery developer with Quoin’s position as a producer of post-surgical pain…

ThursdayFeb 15, 2018 4:15 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) DermSafe Hand Sanitizer Stops Influenza A from Spreading

Skinvisible (OTCQB: SKVI), a developer of innovative drug delivery technology, through its Kintari subsidiary, produces the hand sanitizer, DermSafe®. The DermSafe® hand sanitizer stops the spread of the influenza A (H3N2) virus by hand contact. An article discussing the company reads: “DermSafe employs Skinvisible’s patented polymer delivery system, Invisicare®, which improves the delivery of topically applied skin care products, thereby enhancing the efficacy of the active ingredients. The unique process extends the time that the product remains active on the skin and is specifically formulated to transport active ingredients that are insoluble in water without using alcohol, silicones, waxes or…

MondayFeb 12, 2018 4:46 pm

Skinvisible, Inc. (SKVI) Products Can Offer Protection against Highly Contagious Viruses like H3N2

2018 flu season could cost U.S. businesses $15 billion in lost productivity Winter Olympics hit with norovirus, sickening 128 Olympic workers Centers for Disease Control and Prevention urging public to wash hands, use hand sanitizer in battle against infection DermSafe® antimicrobial hand sanitizer is 99.9 percent effective against a list of deadly bacteria and viruses It’s a simple phrase: “Wash your hands and use a hand sanitizer,” but doing it correctly and with the right product can make the difference when it comes to protection against a nasty bacteria or virus. Using an antiseptic hand sanitizer lotion such as DermSafe®,…

FridayFeb 09, 2018 2:52 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at PTSD-related Suicides through Quoin Partnership

Skinvisible, Inc. (OTCQB: SKVI) is working toward developing a transdermal treatment for post-traumatic stress disorder through its patented Invisicare® technology that could address the devastating number of veteran suicides that occur throughout the country. The company’s proposed merger with Quoin Pharmaceuticals would direct Skinvisible’s drug delivery capacity to boost the bioavailability of Quoin’s promising pharmaceuticals. An article discussing this reads: “Skinvisible, through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., has already developed, licensed and sold multiple dermatology and health care products, as well as various medical treatments, using its patented Invisicare® technology. … Quoin’s two lead products are targeting crises…

MondayFeb 05, 2018 2:49 pm

Skinvisible, Inc. (SKVI), Quoin Pharmaceuticals Proposed Merger to Address Opioid Pain Management Market

A merger between Skinvisible and Quoin will enable a successful entry on the post-surgical pain management market Opioids – which typically refer to oxycodone, hydrocodone, and fentanyl – are highly addictive painkillers; nearly three in 10 Americans prescribed opioids for chronic pain will abuse them Opioids are becoming increasingly deadly to Americans; in 2016, two-thirds of drug-related deaths involved opioids; in fact, since 1999, opioid-related deaths in the United States have increased nearly fourfold Drug abuse is a burden shared by every state; nearly 63,600 Americans lost their lives to drug overdoses in 2016 – a 21 percent increase over…

TuesdayJan 30, 2018 12:22 pm

QualityStocksNewsBreaks – Skinvisible, Inc.’s (SKVI) DermSafe Offers Long-term Protection Against H3N2 Flu Virus

Skinvisible’s (OTCQB: SKVI) innovative DermSafe product incorporates the company’s proprietary Invisicare® drug delivery technology and has proven effective against a variety of infectious germs. An article discussing the topical and transdermal product development company reads: “The main curse this season is the particularly malevolent influenza virus H3N2. It is the most dominant strain not only in the U.S. but in Canada and the UK. The virus, experts believe, is mainly transmitted through the air by droplets formed when infected persons cough, sneeze or talk. These droplets land on hard surfaces like door knobs and as soon as one touches it…

MondayJan 29, 2018 3:35 pm

DermSafe from Skinvisible, Inc. (SKVI) Kills Killer Flu Virus H3N2 For Up to Four Hours

DermSafe® hand sanitizer stops spread of virus by hand contact Now available in Canada and China Employs patented drug delivery technology As deaths across the nation rise, families of victims struck down by the influenza A (H3N2) virus are beginning to sound the alarm (http://ibn.fm/DJ4V0). Warning calls by the relatives of Emily Muth (5), Dylan Winnik (12), Alyssa Alcaraz (12) and Alani Murrieta (20), all of whom succumbed to the deadly strain, relate how murderous this year’s outbreak has been so far. Further proof is furnished by the latest report (http://ibn.fm/lRZZK) from the Centers for Disease Control and Prevention (CDC),…

ThursdayJan 25, 2018 12:22 pm

QualityStocksNewsBreaks – Skinvisible, Inc. (SKVI) to Enter Pain Management Therapeutics Market through Proposed Merger

Skinvisible (OTCQB: SKVI), a developer of innovative drug delivery technology, recently entered a Letter of Intent (“LOI”) regarding a proposed merger with Quoin Pharmaceuticals. The projected merger would mark the company’s entrance into the pain management therapeutics market. An article discussing the topical and transdermal product development company reads: “Skinvisible has a long, successful history developing and licensing Invisicare®, its patented polymer technology. Enhancing how drugs are delivered on, in, or through the skin, Invisicare® has proven efficacy in a wide range of dermatology and health care products, including products to treat acne, skin cancers, eczema, fungal infections, inflammation, warts…

WednesdayJan 24, 2018 4:51 pm

Proposed Transdermal Treatment for Veterans with PTSD a Top Priority of Skinvisible, Inc. (SKVI) and Quoin Pharmaceuticals

Proposed transdermal product will help veterans struggling with PTSD and suicidal thoughts Majority of suicides among military veterans are among those 50 and older Suicide rate for U.S. women veterans was 2.5 times higher than civilian adult women Presidential executive order signed January 9, 2018, focuses on providing mental health care to former service members Topical and transdermal product development company Skinvisible, Inc. (OTCQB: SKVI) and its patented Invisicare® technology could provide significant relief to veterans with post-traumatic stress disorder through a proposed transdermal treatment the company expects to develop as it merges with Quoin Pharmaceuticals Ltd. The proposed merger,…

Site Search

Company Search

Tag: Skinvisible, Inc. SKVI